Traditional Chinese medicine composition for treating thrombocytopenia

Abstract

The invention discloses a traditional Chinese medicine composition for treating thrombocytopenia. The traditional Chinese medicine is composed of following raw materials including, by weight, 3-5 parts of rubia cordifolia, 4-5 parts of forsythia suspense, 3-5 parts of kadsura interior, 2-4 parts of eclipta prostrate, 5-7 parts of flos citri sarcodactylis, 2-3 parts of cirsium japonicum, 6-8 parts of radix astragali, 6-7 parts of semen raphani, 9-11 parts of calyx kaki, 6-8 parts of mulberries, 2-4 parts of processed fallopia multiflora, 10-12 parts of dandelion, 4-6 parts of radix anemones rivularis, 3-5 parts of vinegar processed ginseng, 10-15 parts of barley melt, 4-6 parts of walnut flower, 2-4 parts of solidago canadensis, 1-3 parts of linearleaf vetchling, 1-2 parts of polystichum lichiangense and 2-4 parts of fructus gleditsiae. The traditional Chinese medicine composition has effects of reinforcing healthy qi and strengthening body, boosting qi and nourishing blood, activating blood and resolving stasis, nourishing yin and downbearing fire, nourishing liver and tonifying kidney, tonifying kidney and securing essence, and warming and tonifying kidney yang. The traditional Chinese medicine composition, which is a pure traditional Chinese medicine preparation, is used for treating thrombocytopenia. The composition can quickly effect and clinical syndromes can disappear quickly. The composition is slight in toxic and side effects and is short in course of treatment.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating thrombocytopenia, belonging to the field of traditional Chinese medicines. Background technique [0002] Platelet disorders are caused by poor hemostatic clot formation and bleeding due to decreased platelet count or function; the platelet count is below the normal range of 140,000-400,000 / μl; Retention, increased platelet destruction or utilization, and dilution, severe thrombocytopenia, regardless of cause, can cause typical bleeding: multiple ecchymoses, most often on the lower legs; or small scattered ecchymosis; mucosal bleeding; massive bleeding after surgery; massive bleeding in the gastrointestinal tract and internal bleeding in the central nervous system can be life-threatening; current clinical drugs mainly include adrenal cortex hormones, immunosuppressants, etc., but the adverse reactions are severe, and patients often cannot tolerate them. Accepted; Biologica...

AI Technical Summary

Problems solved by technology

[0002] Platelet disorders are caused by poor hemostatic clot formation and bleeding due to decreased platelet count or function; the platelet count is below the normal range of 140,000-400,000 / μl; Retention, increased platelet destruction or utilization, and dilution, severe thrombocytopenia, regardless of cause, can cause typical bleeding: multiple ecchymoses, most often on the lower legs; or small scattered ecchymosis; mucosal bleeding; massive bleeding after surgery; massive bleeding in the gastrointestinal tract and internal bleeding in the central nervous system can be life-threatening; current clinical drugs mainly include adrenal cortex hormones, immunosuppressants, etc., but the adverse reactions are severe, and patients often cannot tolerate them. Accepted; biological drugs such as thrombopoietin and IL-6, etc., have good curative effect and few side effects, but are expensive